Literature DB >> 7323421

Glomerular filtration barrier in aminoglycoside-induced nephrotoxic acute renal failure.

F C Luft, A P Evan.   

Abstract

To elucidate the role of the glomerular filtration barrier in the development of nephrotoxic acute renal failure, we produced acute renal failure in rats with either gentamicin or tobramycin. Both drugs evoked changes in the glomerular capillary endothelium. Gentamicin administration resulted in a dose-related decrease in the diameter, density and area of endothelial fenestrae, which was considerably more pronounced than those observed with tobramycin. Prolonged, high-dose gentamicin administration caused a decrease in creatinine clearance, an increase in plasma renin activity and a corresponding decrease in the area available for filtration. These changes reverted with continued drug administration. These results support the notion that morphological alterations in the filtration barrier are responsible for the decrease in filtration observed in acute renal failure. The changes may be at least in part mediated by the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7323421     DOI: 10.1159/000172770

Source DB:  PubMed          Journal:  Ren Physiol        ISSN: 0378-5858


  3 in total

1.  Effects of diltiazem on netilmicin-induced nephrotoxicity in rabbits.

Authors:  O Lortholary; F Blanchet; D Nochy; D Heudes; N Seta; P Amirault; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

2.  Endothelial characteristics of glomerular capillaries in normal, mercuric chloride-induced, and gentamicin-induced acute renal failure in the rat.

Authors:  R E Bulger; G Eknoyan; D J Purcell; D C Dobyan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

Review 3.  Renal ultrastructural and biochemical injuries induced by aminoglycosides.

Authors:  C Cojocel; N Docius; K Maita; J H Smith; J B Hook
Journal:  Environ Health Perspect       Date:  1984-08       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.